DRG 476 Overview

DRG 476 covers inpatient admissions for surgical amputation procedures related to musculoskeletal system and connective tissue disorders without a Complication or Comorbidity or Major Complication or Comorbidity. This category includes primary amputations when no significant comorbid conditions are coded that would increase resource use. It matters for Medicare payment because the Diagnosis-Related Group assignment directly influences the bundled inpatient reimbursement amount for the episode of care. Accurate clinical coding and documentation determine eligibility for this Diagnosis-Related Group and therefore affect payment level.

• Acute perioperative wound management and infection-prevention trials: studies testing different surgical site infection prevention bundles, dressing types, or perioperative antibiotic strategies in adults undergoing major lower-limb amputation for musculoskeletal or connective tissue disorders (for example severe osteomyelitis, non-reconstructable ischemic limb complications, or tumor-related resections). These trials focus on the immediate inpatient period and measure outcomes such as surgical site infection rates, reoperation, length of stay, and early wound healing, which directly affect hospital resource use and DRG payments. Evidence from this area informs surgeons and hospital administrators about interventions that can reduce complications and avoid costly readmissions for this DRG population.
• Comparative effectiveness and rehabilitation trials evaluating stump-preservation techniques and timing of prosthetic fitting: randomized or pragmatic cohort studies comparing different amputation levels, closure techniques, or accelerated versus delayed prosthetic fitting programs in patients whose amputations are for non-traumatic musculoskeletal or connective tissue indications. These studies enroll patients with varied comorbidity profiles (e.g., diabetes, peripheral vascular disease, chronic inflammatory disorders) to assess functional outcomes, prosthesis use, mobility scores, and subsequent healthcare utilization over months to a year. Results are relevant to payers and providers because they affect downstream costs, long-term independence, and the need for repeat surgeries or extended rehabilitation services beyond the initial DRG encounter.
• Post-discharge outcomes and care coordination studies focusing on readmission reduction and long-term complication surveillance: observational cohort or implementation science studies that test discharge pathways, home health models, telemonitoring, and multidisciplinary clinics for patients after lower-limb amputation for musculoskeletal/connective tissue diseases. These studies target high-risk subgroups (those with multiple comorbidities, prior infections, or social determinants that limit outpatient access) and measure 30- and 90-day readmissions, wound complications, emergency visits, and total cost of care. Findings help hospitals and payers design transition-of-care programs that reduce avoidable readmissions and align incentives under bundled payment or value-based reimbursement for this DRG.